OmniSeq INSIGHT is a comprehensive, tissue-based, next generation sequencing genomic profiling device clinically and analytically validated for all solid tumors. The test is designed to detect genomic variants, signatures, and immune gene expression to provide physicians with clinically actionable evidence to inform therapeutic treatment decisions and identify potential clinical trial options based on an individual genomic profile of each patient. Results are intended for use by qualified health care professionals in accordance with professional guidelines in oncology for management of patients with solid neoplasms, and is not conclusive or prescriptive for labeled use of any specific therapeutic product.